1. Chang BS, Lowenstein DH. Epilepsy. N Eng J Med 2003;349:1257-1266.

2. Jędrzejczak J. Padaczka. Wydawnictwo Czelej. Lublin 2006; s. 13-19.

3. Jędrzejczak J. Padaczka Najtrudniejsze są odpowiedzi na proste pytania. Wydawnictwo Termedia. Poznań 200; s. 1-7.

4. Buckley BM. Healthy ageing: ageing safely. Eur Heart J. 2001;3 suppl N: 6-10.

5. Kannel WB. The demographics of claudication and aging of the American population. Vasc Med 1996;1: 60-64.

6. World Population Prospects. The 2006 Revision and World Urbanisation Prospects: The 2006 Revision. http:// esa.un.org/unpp/

7. Gabr WM, Shams ME. Adherence to medication among outpatient adolescents with epilepsy. Saudi Pharm J. 2015 Jan;23(1):33-40.

8. Samsonsen C, Reimers A, Bråthen G, et al. Nonadherence to treatment causing acute hospitalizations in people with epilepsy: an observational, prospective study. Epilepsia. 2014, 55(11):125-128.

9. McGrath A, Sharpe L, Lah S, Parratt K. Pregnancy-related knowledge and information needs of women with epilepsy: A systematic review. Epilepsy Behav 2014;31:246- 255

10. Ridsdale L, Robins D, Fitzgerald A, Jeffery S, McGee L. Epilepsy monitoring and advice recorded: general practitioners’ views, current practice and patients’ preferences. Br J Gen Pract. 1996 Jan;46(402):11-4.

11. Tan M. Epilepsy in adults. Aust Fam Physician. 2014;43(3):100-104.

12. 12 Jędrzejczak J. Kobieta z padaczką. Jędrzejczak J, Majkowska- Zwolińska B (red.). Padaczka u kobiet. Elsevier Urban&Partner. Wrocław 2013.

13. Abe K, Hamada H, Yamada T, et al. Impact of planning of pregnancy in women with epilepsy on seizure control during pregnancy and on maternal and neonatal outcomes. Seizure 2014;23(21):112-116

14. Tatum WO. In utero antiepileptic drug exposure. Expert Rev Neurother 2006;6:1785-1787.

15. Hermandez-Diaz S, Smith CR, Shen A, et al. Comparative of anticonvulsants during pregnancy: seizures or major malformations. Pharmacoepidemiology and Drug Safety 2011; 20:11.

16. Tomson T, Battino D, Bonizzioni E, et al. Dose.-dependent risk malformations with antiepileptic drugs: an analysis of data from EURAP epilepsy and pregnancy registry. Lancet Neurol 2011;10: 609-617.

17. Meador K, Reynolds MW, Crean S, Fahrbach K, Probst C. Pregnancy outcomes in women with epilepsy: a systematic review and meta-analysis of published pregnancy registries and cohorts. Epilepsy Res. 2008;81(1):1-13.

18. Kennedy F, Morrow J, Hunt S, Russell A, Smithson WH, Parsons L et al. UK Pregnancy and Epilepsy Register (2010) malformation risks of antiepileptic drugs (eds) in pregnancy: an update from the UK Epilepsy and Pregnancy register. Epilepsia 51;(Suppl. 4):10.

19. Krishnamurthy KB. Managing epilepsy during pregnancy: assessing risk and optimizing care. Curr Treat Options Neurol 2012;14(4):348-255.

20. Harden CL, Pennell PB, Koppel BS, et al. Report of the Quality Standards Subcommittee and Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology and the American Epilepsy Society: Management issues for women with epilepsy--focus on pregnancy (an evidence-based review): III. Vitamin K, folic acid, blood levels, and breast-feeding. Epilepsia 2009;50:1247-1255.

21. Patsalos PN, Fröscher W, Pisani F, et all. The importance of drug interactions in epilepsy therapy. Epilepsia. 2002;43(4):365-385.

22. Zaccara G, Perucca E. Interactions between antiepileptic drugs, and between antiepileptic drugs and other drugs. Epileptic Disord. 2014;16(4):409-431.

23. Perucca E. Adverse effects of antiepileptic drugs Focus. Farmacovigilanza 2014;80(1):1.